BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 2:41:00 PM | Browse: 783 | Download: 676
Publication Name World Journal of Gastroenterology
Manuscript ID 6655
Country Italy
Received
2013-10-26 12:24
Peer-Review Started
2013-10-27 12:24
To Make the First Decision
2014-01-09 12:33
Return for Revision
2014-01-11 19:17
Revised
2014-01-22 17:00
Second Decision
2014-02-27 11:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-02-27 11:28
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-03-26 11:19
Publish the Manuscript Online
2014-04-14 10:49
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Inhibition of host immune response in colorectal cancer: Human leukocyte antigen-G and beyond
Manuscript Source Invited Manuscript
All Author List Marica Garziera and Giuseppe Toffoli
Funding Agency and Grant Number
Funding Agency Grant Number
Associazione Italiana per la Ricerca sul Cancro (AIRC), Special Program Molecular Clinical Oncology, 5X1000 12214 (G.T.)
European Research Council, Programme ‘‘Ideas’’, Proposal 269051 (G.T., F.R.)
Corresponding Author Marica Garziera, PhD, Experimental and Clinical Pharmacology Unit, CRO Aviano National Cancer Institute, via Franco Gallini 2, 33081 Aviano, Italy. mgarziera@cro.it
Key Words Colorectal cancer; Human leukocyte antigen-G; Immune score; T lymphocytes; Untranslated regions
Core Tip Colorectal cancer (CRC) prognosis is strictly associated with the immune contexture of tumor microenvironment. IS improves prognostic prediction in CRC. Human leukocyte antigen-G (HLA-G) through its direct inhibitory functions on NK cells and cytotoxic T and B lymphocytes represents a crucial tumor-driven immune escape molecule. This review highlights the current knowledge on HLA-G in CRC and in related inflammatory diseases. HLA-G genetic setting and circulating/soluble profiles need to be defined to comprehend CRC strategies to avoid host immune defences. We suggest that HLA G could represent a novel prognostic immune biomarker to associate with the Immune Score to better characterize host immune response in CRC.
Publish Date 2014-04-14 10:49
Citation Garziera M, Toffoli G. Inhibition of host immune response in colorectal cancer: Human leukocyte antigen-G and beyond. World J Gastroenterol 2014; 20(14): 3778-3794
URL http://www.wjgnet.com/1007-9327/full/v20/i14/3778.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i14.3778
Full Article (PDF) WJG-20-3778.pdf
Full Article (Word) WJG-20-3778.doc
Manuscript File 6655-Review.doc
Answering Reviewers 6655-Answering reviewers.pdf
Copyright License Agreement 6655-Copyright assignment.pdf
Peer-review Report 6655-Peer review(s).pdf
Scientific Editor Work List 6655-Scientific editor work list.doc